Larson Financial Group »

Unicycive Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $938 200 4.69

More positions owned by Larson Financial Group

Spdr Series Trust St Str P500etf (SPYM)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Apple (AAPL)
Applied Materials (AMAT)
Capital Group Global Equity SHS (CGGE)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Capital Grp Fixed Incm Etf T Core Bond Etf (CGCB)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Lam Research Corp Com New (LRCX)

View all positions for Larson Financial Group

Top funds holding Unicycive Therapeutics

BlackRock
Nantahala Capital Management
Diadema Partners
Vanguard Capital Management
Octagon Capital Advisors
Susquehanna International
Geode Capital Management
Vivo Capital
Marshall Wace
Caption Management
Logos Global Management
Diametric Capital
J. Goldman & Co
Citadel Advisors
Millennium Management

View all funds holding Unicycive Therapeutics